The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
A Mouse Model of the Human Fragile X Syndrome I304N Mutation
Open accessAbstract
The mental retardation, autistic features, and behavioral abnormalities characteristic of the Fragile X mental retardation syndrome result from the loss of function of the RNA-binding protein FMRP. The disease is usually caused by a triplet repeat expansion in the 5'UTR of the FMR1 gene. This leads to loss of function through transcriptional gene silencing, pointing to a key function for FMRP, but precluding genetic identification of critical activities within the protein. Moreover, antisense transcripts (FMR4, ASFMR1) in the same locus have been reported to be silenced by the repeat expansion. Missense mutations offer one means of confirming a central role for FMRP in the disease, but to date, only a single such patient has been described. This patient harbors an isoleucine to asparagine mutation (I304N) in the second FMRP KH-type RNA-binding domain, however, this single case report was complicated because the patient harbored a superimposed familial liver disease. To address these issues, we have generated a new Fragile X Syndrome mouse model in which the endogenous Fmr1 gene harbors the I304N mutation. These mice phenocopy the symptoms of Fragile X Syndrome in the existing Fmr1-null mouse, as assessed by testicular size, behavioral phenotyping, and electrophysiological assays of synaptic plasticity. I304N FMRP retains some functions, but has specifically lost RNA binding and polyribosome association; moreover, levels of the mutant protein are markedly reduced in the brain specifically at a time when synapses are forming postnatally. These data suggest that loss of FMRP function, particularly in KH2-mediated RNA binding and in synaptic plasticity, play critical roles in pathogenesis of the Fragile X Syndrome and establish a new model for studying the disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Expression of FMRP in Fmr1 I304N and WT littermates. (A) 50 ug of brain lysate from three Fmr1 I304N mice and three wild type littermates at P14, 2 mo, and 6 mo of age, were analyzed by Western blot for steady state FMRP expression using the anti-FMRP C-terminus antisera ab17722 (Abcam) and gamma-tubulin as a loading control. (B) Signal was quantified by chemiluminescence using Versadoc imaging and the percentage of I304N-FMRP signal compared to wild type FMRP is indicated. Error bars reflect the standard deviation of three mice. This experiment has been repeated several times and with different antibodies to FMRP (Chemicon ab2160 (1C3), 2F5 [84], and 7G1-1 [85] with consistent results. (C) 50 ug of brain lysate from P14 mice of the indicated genotype (littermates) was analyzed for expression of FMRP with ab17722, FXR1P, FXR2P, and gamma-tubulin. (D) 50ug of testes or spleen lysate from the same animals at P60 was analyzed in the same way with ab17722, and normalized to Hsp90 levels. (E) Brain lysates for polyribosome analysis were prepared from Fmr1 I304N mice and WT littermates, and fractionated over linear 20%–50% sucrose gradients. The levels of Fmr1 mRNA and Gapdh mRNA were quantified in each fraction by quantitative RT–PCR using the ΔΔCt method. An A254 absorption profile from one of the WT mice is shown in the upper panel and the 80S monosome and polyribosomes are indicated. Other gradients were indistinguishable within a WT and I304N littermate pair. Relative mRNA level in each fraction was plotted as a percentage of total mRNA to illustrate its distribution over the polyribosome gradient. Error bars reflect three technical replicates from a single littermate pair. The experiment has been repeated with additional littermate pairs, but cannot be plotted on one graph due to variable fraction collection between experiments. Representative graphs are shown.](https://figures.cochat.ai/paper-figures/cef27329de1f48c4a4dd80757f7d3102/a-mouse-model-of-the-human-fragile-x-syndrome-i304n-mutation-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a missense mutation in the second RNA binding domain (I304N) abolishes FMRP polyribosome association (Zang et al., 2009; Feng et al., 1997a) and causes a Fragile X phenotype in mice (Zang et al., 2009) and humans (DeBoulle et al., 1993).”
From FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism (2011) · cites this paper as Zang et al., 2009
In the citing paper
“Studies of Fmr1 knockout (KO) and I304N mice have documented a number of defects in synaptic plasticity (Pfeiffer and Huber, 2009; Zang et al., 2009).”
From FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism (2011) · cites this paper as Zang et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851 · cited 1×
“in genes including neuroligin-3 [1,2], neurexin-1 [3], shank 3 [4],”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 1×
“in genes including neuroligin-3 [1,2], neurexin-1 [3], shank 3 [4],”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 3×
“In Fmr1 null mice, mGluR-LTD elicited by either an mGluR agonist (DHPG) or electrical stimulation of Schaffer collateral inputs to CA1 neurons (paired pulse low frequency stimulation (PP-LFS)) is enhanced [11], and no longer requires protein synthesis [60,61].”
BackgroundSelf-citationCLIP Identifies Nova-Regulated RNA Networks in the Brain
Ule, J., Jensen, K. B., Ruggiu, M., Mele, A., Ule, A., & Darnell, R. B. (2003) · Science · doi:10.1126/science.1090095 · Cited by 1,120 · cited 1×
“-α-GTP. RNAs were gel purified on denaturing gels and spiked into 100ul S2 brain lysate prepared as for polyribosome analysis from 2 month old mice of the indicated genotype. RNAs were incubated with the brain lysates for 15 min at room temperature and then UV crosslinked as described”
MethodSelf-citationBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 2×
“This experiment has been repeated several times and with different antibodies to FMRP (Chemicon ab2160 (1C3), 2F5 [84], and 7G1-1 [85] with consistent results.”
MethodSelf-citationAbnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046 · cited 1×
“This mouse has defects in synaptic plasticity [11–18] and long, thin dendritic spines [19,20] similar to those found in human brain [21,22].”
BackgroundFmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
Cited by
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Self-citationMolecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528
The translation of translational control by FMRP: therapeutic targets for FXS
Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491
Self-citationRNA-binding proteins in Mendelian disease
Castello, A., Fischer, B., Hentze, M. W., & Preiss, T. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.01.004 · Cited by 255
Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction
Phan, A. T., Kuryavyi, V., Darnell, J. C., Serganov, A., Majumdar, A., Ilin, S., Raslin, T., Polonskaia, A., Chen, C., Clain, D., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2064 · Cited by 257
Self-citation
Metadata
- Authors
- Zang, J. B., Nosyreva, E. D., Spencer, C. M., Volk, L. J., Musunuru, K., Zhong, R., Stone, E. F., Yuva-Paylor, L. A., Huber, K. M., Paylor, R., Darnell, J. C., & Darnell, R. B.
- Affiliations
- Rockefeller University (US)
- The University of Texas Southwestern Medical Center (US)
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Darnell, Jennifer C.
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-11
- Volume
- 5
- Issue
- 12
- Pages
- e1000758
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC2779495
- OpenAlex
- W1975841935
- Cited by
- 138
- References
- 94
- Citations by year
- 2025: 11 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 12 · 2018: 8 · 2017: 8 · 2016: 8 · 2015: 6 · 2014: 8 · 2013: 19 · 2012: 10
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- Autism Speaks
- National Institutes of Health (IA 52242, R01 NS34389, NS34389)
- Directorate for Biological Sciences
- National Institute of General Medical Sciences (GM 07739, T32GM007739)
- National Institute of Neurological Disorders and Stroke (R01NS040955, R01 NS34389, R01NS045711, R01 NS40955, R01NS034389)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD052731, R01HD040647)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- fragile X syndrome, FMRP, mouse model, FMR1 gene, RNA binding, synaptic plasticity, testicular volume, intellectual disability, autism spectrum disorder
- MeSH terms
- Animals, Behavior, Animal, Disease Models, Animal, Fragile X Syndrome, Hippocampus, Humans, Neuronal Plasticity, Phenotype, Mutation, Missense, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Mouse Model of the Human Fragile X Syndrome I304N Mutation. https://app.cochat.ai/papers/10.1371/journal.pgen.1000758
- The paper
- Zang, J. B., Nosyreva, E. D., Spencer, C. M., Volk, L. J., Musunuru, K., Zhong, R., Stone, E. F., Yuva-Paylor, L. A., Huber, K. M., Paylor, R., Darnell, J. C., & Darnell, R. B. (2009). A Mouse Model of the Human Fragile X Syndrome I304N Mutation. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1000758
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.